Phase III trial to compare the immunogenicity of hepatitis B vaccine 1018-ISS conjugate with that of recombinant hepatitis B vaccine in adults 40-70 years of age.
Phase of Trial: Phase III
Latest Information Update: 13 Feb 2012
At a glance
- Drugs Hepatitis B vaccine recombinant; V 270
- Indications Hepatitis B
- Focus Pharmacodynamics; Therapeutic Use
- 13 Feb 2012 Results published in Vaccine.
- 19 Sep 2007 Results have been reported at ICAAC 2007.
- 30 Nov 2006 Status change
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History